Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospecti
详细信息 查看全文
- 作者：Bevilacqua ; Maurizio ; Guazzini ; Barbara ; Righini ; Velella ; Barrella ; Massimo ; Toscano ; Rosanna ; et. al.
- 关键词：fluvastatin XL ; atorvastatin ; type 2 DM ; HDL ; LDL ; triglycerides ; apo A-I ; apo B
- 刊名：Current Therapeutic Research
- 出版年：2004
- 出版时间：July - August, 2004
- 年：2004
- 卷：65
- 期：4
- 页码：330-344
- 全文大小：845 K
文摘
Diabetic dyslipidemia is characterized by greater triglyceridation of all lipoproteins and low levels of plasma high-density lipoprotein cholesterol (HDL-C). In this condition, the serum level of low-density lipoprotein cholesterol (LDL-C) is only slightly elevated. The central role of decreased serum HDL-C level in diabetic cardiovascular disease has prompted the establishment of a target of ≥50 mg/dL in patients with diabetes mellitus (DM).